RecruitingNCT06759961
Post-transplant Thrombotic Microangiopathy: Evaluation of Outcomes at the Bologna Kidney Transplant Centre
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
250 participants
Start Date
Feb 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
It is a retrospective-prospective, single-centre, non-pharmacological, retrospective tissue study carried out for scientific and health protection purposes. It involves the systematic collection of clinical information from patients diagnosed with PT-TMA
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age ≥ 18 years
- Living kidney transplant recipient, brain death cadaver donor, cardiac death cadaver donor, single kidney transplant, double kidney transplant, combined kidney transplant
- Acquisition of Informed Consent to participate in the study and to process personal, special and genetic data
Exclusion Criteria1
- \-
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06759961
Related Trials
Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients
NCT068334636 locations
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
NCT06830798130 locations
Kidney Protective Jacket
NCT073484581 location
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
NCT0591752215 locations
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
NCT068324107 locations